Baden-Württemberg Politician, Emil Sänze MdL, Advocates for the Preservation of the Region's Pharmaceutical Research Center
Title: AfD Pressures Baden-Württemberg Government on BioNTech Takeover and Location Strategy
Hey there! Let's discuss the AfD's recent concern over BioNTech's acquisition plans and their call for a strategic location policy in Baden-Württemberg.
Here's the gist: In 2020, the German state invested 300 million euros in Curevac, and BioNTech - a significant recipient of taxpayer funds - is now buying Curevac for 1.25 billion euros! The deal, which resolves ongoing patent disputes between the companies, is expected to close by the end of 2025. The AfD's finance spokesman, Emil Saenze, insists that this is the perfect moment for the state government to strategize its location policy like never before.
According to him, with BioNTech and Curevac heavily backed by taxpayers’ money, the research expertise created should not be sold off to external decision-makers but rather kept in the region. To prevent this, Josef Walter, the AfD's press spokesman, has urged Economic Minister Hoffmeister-Kraut to intervene and ensure that the research expertise in question does not fall into the wrong hands.
While the connection is not directly established, the AfD's call for a strategic location policy reflects growing political interest in supporting the domestic biotech and pharmaceutical industry. However, it remains unclear if and how BioNTech's acquisition is influenced by these political concerns.
Stay tuned for more updates on this developing story! If you have any questions or want to learn more about BioNTech and Curevac, feel free to ask!
```Contact Information:Mobile: +49 151 14607482Tel.: +49 711 2063-5042E-Mail: josef.walter@afd.landtag-bw.de
Mailing Address:AfD Fraction in the Baden-Württemberg State Parliamentc/o Josef WalterKonrad-Adenauer-Straße 370173 Stuttgart
Visiting Address:AfD Fraction in the Baden-Württemberg State ParliamentHouse of Parliament: U32/305Urbanstraße 3270182 Stuttgart```
- The AfD's finance spokesman, Emil Saenze, suggests that the Baden-Württemberg government should strategize its location policy in light of BioNTech's acquisition of Curevac, as both companies have received significant investments from the state, potentially impacting the local business and finance sectors.
- With the political interest growing in supporting the domestic biotech and pharmaceutical industry, there are questions regarding whether BioNTech's acquisition by Curevac is influenced by these political concerns, particularly as it could influence the industry's future and the finance sector.
- The general news is abuzz with the ongoing debate surrounding BioNTech's acquisition of Curevac, following the AfD's call to keep the research expertise created by these companies within the region, impacting the local economy, finance, and politics.